Anti-Surrogacy Group Files Amicus Brief With Colombia’s Constitutional Court: What Intended Parents Should Know
Colombia’s surrogacy debate is moving beyond Congress and into the country’s highest constitutional court.
On June 18, 2026, the International Coalition for the Abolition of Surrogate Motherhood published an amicus curiae submission addressed to Colombia’s Constitutional Court concerning two surrogacy-related proceedings: files T-11.055.661 and T-11.092.074 AC. The document itself is dated June 2, 2026.
The organization argues that surrogacy—whether described as commercial or altruistic—can turn pregnancy and women’s reproductive capacity into matters of contractual control.
For international intended parents considering surrogacy in Colombia, this is a development worth understanding.
It does not mean that Colombia has prohibited surrogacy.
It does not mean the Constitutional Court has accepted the organization’s arguments.
But it does show that Colombia’s future surrogacy framework is increasingly being debated through the language of human rights, women’s autonomy, child protection, and contractual ethics.
What Is an Amicus Curiae?
An amicus curiae, or “friend of the court,” is a written submission made by an organization or expert that is not one of the main parties to the case.
Its purpose is to provide the court with additional legal arguments, research, policy analysis, or international perspectives.
An amicus submission is not a judgment.
It does not automatically change the law.
The Constitutional Court remains free to accept, reject, or give limited weight to the arguments presented.
Nevertheless, submissions of this kind can influence how judges frame the legal questions before them—especially when a country does not yet have comprehensive national surrogacy legislation.
What Does the Anti-Surrogacy Organization Argue?
The submission relies on Colombian and comparative legal materials and presents surrogacy as a practice that may conflict with the dignity, autonomy, and rights of women and children.
Its central concern is that a surrogacy agreement may place pregnancy within a contractual structure in which another party expects control over medical decisions, conduct during pregnancy, delivery, and relinquishment of the child.
The organization’s position is broader than criticism of poorly managed commercial programs.
It challenges the ethical legitimacy of surrogacy itself.
That distinction matters.
Some critics argue that surrogacy should be regulated more carefully.
Abolitionist organizations argue that it should ultimately be eliminated.
Does This Mean Colombia Surrogacy Is About to Be Banned?
No.
An amicus brief is an advocacy document, not a ruling or statute.
Colombia still does not have a comprehensive national law expressly authorizing or prohibiting every form of surrogacy. The current framework continues to rely heavily on constitutional jurisprudence, family-law procedures, medical documentation, and case-specific judicial review. A 2026 academic study describes this regulatory gap and proposes a structured transactional framework rather than assuming that prohibition is the only option.
The Constitutional Court has considered surrogacy and assisted-reproduction questions before, including in decisions such as T-968 of 2009 and T-127 of 2024. The newly submitted amicus brief itself cites several of these Colombian decisions.
The immediate practical effect is therefore limited.
Surrogacy programs have not stopped simply because the submission was filed.
However, the political and judicial environment is clearly becoming more demanding.
Why This Development Still Matters
Colombia’s surrogacy market has grown rapidly because it offers international intended parents a combination of experienced IVF care, donor programs, gestational carriers, lower costs than the United States, and established legal practice.
Rapid growth also attracts scrutiny.
Courts, journalists, academics, women’s-rights organizations, and international advocacy groups increasingly ask whether:
- Surrogates give fully informed and independent consent.
- Financial vulnerability affects their decisions.
- Contracts improperly control medical choices.
- Agencies disclose all risks and payments.
- Children receive secure identity and parentage documentation.
- Intended parents have a legally viable post-birth plan.
- Clinics and intermediaries are subject to meaningful oversight.
A responsible Colombia surrogacy provider cannot dismiss these questions as hostile propaganda.
They are precisely the questions the industry must answer through better standards.
The Strongest Response Is Not Marketing—It Is Ethical Practice
The right response to anti-surrogacy criticism is not to claim that every Colombia program is automatically ethical.
That is plainly not true.
Programs differ significantly in their medical standards, surrogate recruitment, psychological screening, payment structures, legal documentation, and post-birth support.
The strongest response is to demonstrate that an ethically managed program includes:
- Independent legal advice for the surrogate.
- Genuine informed consent before treatment.
- Medical and psychological screening.
- Freedom from coercion.
- Clear and documented financial support.
- Protection of the surrogate’s medical decision-making.
- Appropriate insurance and pregnancy care.
- A clear genetic, parentage, nationality, and birth-registration plan.
- Long-term recordkeeping for the child.
These protections do not eliminate every philosophical objection to surrogacy.
But they directly address the practical risks most often raised by courts and human-rights advocates.
Why the Language Used in Surrogacy Matters
International agencies should also reconsider how they describe their programs.
Phrases such as “renting a womb,” “buying a baby,” or treating a surrogate as a replaceable service provider reinforce the very concerns abolitionist organizations raise.
A responsible program should describe the process accurately:
- The surrogate is a person, not a product.
- Compensation or reimbursement must be transparent and ethically structured.
- Medical consent belongs to the pregnant woman.
- The child is not the subject of a sale.
- Intended parenthood must be supported by lawful reproductive intent and a valid post-birth legal pathway.
Language alone does not create ethical practice.
But careless language often reveals careless thinking.
What Intended Parents Should Ask Before Signing
The filing of this amicus brief makes due diligence even more important.
Before entering a Colombia surrogacy program, intended parents should ask:
Does the surrogate receive independent legal advice?
Who performs her psychological assessment?
How are payments and pregnancy-related expenses documented?
Can she make independent medical decisions?
What happens if serious complications arise?
Does at least one intended parent have the genetic connection required for the planned nationality and travel pathway?
How will the child’s initial birth registration be handled?
What court procedures may be required after birth?
Who remains responsible for the case after delivery?
A legitimate agency should answer these questions directly.
Regulation May Be More Likely Than Immediate Prohibition
Colombia’s current debate contains two very different visions.
One seeks abolition.
The other seeks clearer regulation.
Recent scholarship proposes a “transactional regulation” model that would formalize consent, eligibility, contracts, institutional supervision, and human-rights safeguards, drawing comparative lessons from Mexico’s Tabasco and Sinaloa frameworks.
In practical terms, Colombia may eventually move toward:
- Stronger surrogate screening.
- More formal contracts.
- Independent legal representation.
- Better clinic oversight.
- Clearer rules for parentage.
- Greater protection of children’s identity.
- More transparent compensation structures.
For professionally managed programs, such reforms may increase costs and documentation requirements.
They may also improve predictability and legitimacy.
The Canbaby Surrogacy Perspective
At Canbaby Surrogacy, we do not believe criticism of the industry should simply be ignored.
Some international surrogacy practices deserve criticism.
Poor recruitment, hidden fees, weak medical oversight, misleading legal promises, and inadequate surrogate protection damage families and undermine public trust.
Our position is that Colombia surrogacy must be built around four principles:
medical responsibility, legal transparency, surrogate protection, and the best interests of the child.
As an embryologist-led team, we evaluate more than whether an embryo can be transferred.
We consider whether the surrogate has been appropriately screened, whether the embryo offers a medically reasonable chance of success, whether the intended parents have a viable legal pathway, and whether the child can safely obtain identity and travel documentation after birth.
The June 2026 amicus submission does not close Colombia’s surrogacy market.
But it sends a clear warning to the industry:
The future will not belong to agencies that depend on secrecy, shortcuts, or low prices alone.
It will belong to programs capable of demonstrating that international surrogacy can be managed with dignity, informed consent, medical ethics, and genuine protection for everyone involved.
Keywords: Colombia Surrogacy 2026, Colombia Constitutional Court Surrogacy, Surrogacy Amicus Curiae Colombia, Colombia Surrogacy Law, Ethical Surrogacy Colombia, Surrogate Protection Colombia, Colombia Gestational Surrogacy, Colombia Surrogacy Human Rights, Colombia Surrogacy Legal Update, Canbaby Surrogacy.
